. Well there were a lot of science experiments that got funded thanks to very low interest rates. Now that they have burnt thru their cash on hand ...good luck on more financing unless they have a truly practice changing drug in development that can leap frog over the competition. Theres no second place winners You need to follow NVS's P3 LN trial with Cosentyx . Readout out apparently Jan 2025 . Since it's a large trial theres probably an interim stop for futility ...and as far as I know it hasn't been stopped yet .
By the way ..is that a death cross on the charts ( for those that follow such things ) 50 day MA crossing below the 200 day MA ? Kiwi
News 
Market Data 
Discover 
